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The residues L40, A113, V291, and V294, in leucine dehydrogenase (LeuDH), 
predicted to be involved in recognition of the substrate side chain, have been mutated on the 
basis of the molecular modeling to mimic the substrate specificities of phenylalanine (PheDH), 
glutamate (GluDH), and lysine dehydrogenases (LysDH). The A113G and A113G/V291L 
mutants, imitating the PheDH active site, displayed activities toward L-phenylalanine and 
phenylpyruvate with 1.6 and 7.8% of kcat values of the wild-type enzyme for the preferred 
substrates, L-leucine and its keto-analog, respectively. Indeed, the residue A113, 
corresponding to G114 in PheDH, affects the volume of the side-chain binding pocket and has 
a critical role in discrimination of the bulkiness of the side chain. Another two sets of mutants, 
substituting L40 and V294 of LeuDH with the corresponding residues predicted in GluDH 
and LysDH, were also constructed and characterized. Emergence of GluDH and LysDH 
activities in L40K/V294S and L40D/V294S mutants, respectively, indicates that the two 
corresponding residues in the active site of amino acid dehydrogenases are important for 
discrimination of the hydrophobicity/polarity of the aliphatic substrate side chain. All these 
results demonstrate that the substrate specificities of the amino acid dehydrogenases can be 
altered by protein engineering. The engineered dehydrogenases are expected to be used for 
production and detection of natural and non-natural amino acids. 
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1.  Introduction 
Leucine dehydrogenase (LeuDH) [EC 1.4.1.9] is an NAD+- dependent 
oxidoreductase that catalyzes the reversible deamination of L-leucine and some other 
branched-chain L-amino acids to their keto analogs (Scheme 1). The enzyme occurs 
ubiquitously in Bacillus species [1] and functions catabolically in the bacterial metabolism of 
branched-chain L-amino acids [2]. It has been suggested that the enzyme plays an important 
role in spore germination in cooperation with alanine dehydrogenase [3, 4]. The amino acid 
dehydrogenase has considerable commercial potential for the production of novel non-
proteinous amino acids in pharmaceutical industries [5, 6] and for the diagnosis of genetic 
diseases of amino acid metabolisms including phenylketonuria [7], maple syrup urine disease 





The thermostable LeuDH cloned from Bacillus stearothermophilus [11] shares 
considerable sequence similarities in the catalytic and coenzyme-binding domains with the 
enzymes acting on other amino acids, such as glutamate (GluDH) [12, 13], phenylalanine 
(PheDH) [14, 15], and valine (ValDH) [16, 17] dehydrogenases. Although the overall 
similarities among these enzymes are not high, sequence similarities between these 
dehydrogenases clearly indicate the existence of an enzyme superfamily related by divergent 
evolution [18]. However, the substrate specificities of this superfamily are different; GluDH 




recognizes and binds glutamate in preference to all other amino acids [19], LeuDH and 
ValDH catalyze the oxidation of only branched-chain, aliphatic amino acids [1, 20, 21], and 
PheDH has a marked preference for aromatic amino acids as its substrate, although it also 
accepts smaller hydrophobic amino acids with reduced efficiency [22, 23]. 
Results of structural studies in the last decade have revealed that these enzymes share 
a very similar subunit structure, with each subunit composed of two domains separated by a 
cleft harboring the active site [24-26]. To study the structure and function of the domains of 
amino acid dehydrogenases before their crystal structures were available, we constructed and 
characterized the chimeric enzyme consisting of an N-terminal domain of thermostable 
PheDH from Thermoactinomyces intermedius and a C-terminal domain of LeuDH from B. 
stearothermophilus [27]. Furthermore, we constructed and expressed genes of fragmentary 
forms of B. stearothermophilus LeuDH to investigate the function of the enzyme domains 
[28]. The results of our domain manipulation have suggested that the substrate specificity is 
determined by structural interactions of the two domains, as corroborated from the presently 
known crystal structures. 
On the basis of the molecular structures of GluDH [24], LeuDH [25], and PheDH 
[26], substrate specificity of amino acid dehydrogenases is explained by the types of residues 
comprising the substrate side-chain binding pocket. In GluDH of Clostridium symbiosum, the 
principal interactions that determine the specificity are between the γ-carboxyl group of the 
substrate glutamate and the amino group of K89 and the hydroxyl group of S380, with G90, 
A163, and V377 interacting with the hydrophobic component of the glutamate side chain [29]. 
In the Bacillus sphaericus LeuDH structure, the latter three residues are conserved (G41, 
A113, and V291, respectively), whereas K89 and S380 in GluDH are replaced by L40 and 
V294 in LeuDH (residue numbers refer to B. sphaericus LeuDH), making up a more 
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hydrophobic substrate side-chain binding pocket [25]. X-ray crystallographic and homology-
based molecular modeling studies of PheDH revealed that this enzyme has a hydrophobic and 
large side-chain binding pocket enough to bind the phenylalanine benzene ring by replacing 
glycine for A113 of LeuDH [18, 30]. 
Several attempts have been made to alter the substrate specificities of the amino acid 
dehydrogenase superfamily by molecular modeling. Wang et al. engineered a K89L/S380V 
double mutant of GluDH, expecting that it would show substrate specificity of LeuDH with a 
hydrophobic pocket [30], but the mutant had no activity because of steric clash of the pocket 
[31]. The substrate specificity of B. sphaericus PheDH was successfully shifted toward that of 
LeuDH by replacing G124 and L307 (corresponding to A163 and V377 in GluDH, 
respectively) to alanine and valine, respectively [32]. More recently, Seah et al. succeeded in 
modulating the specificity of B. sphaericus PheDH [33]. 
In the present study, aiming at altering the substrate specificity of B. 
stearothermophilus LeuDH by homology-based modeling, we chose L40, A113, V291, and 
V294 for a target of mutagenesis to mimic the substrate-binding pocket of PheDH, GluDH, 
and LysDH. The detailed kinetic analysis of the mutant enzymes suggests that these residues 
are important in the substrate side-chain recognition of the enzyme superfamily. The 
alteration of substrate specificity by protein engineering presented here is not only of 
scientific interest – understanding the structural basis for the difference in substrate 
discrimination of the amino acid dehydrogenases – but also of applied one, possibly providing 
an amino acid dehydrogenase with novel properties for production and detection of natural 
and non-natural amino acids. 
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2.  Experimental 
2.1. Materials 
A site-directed mutagenesis kit (Mutan-K), Taq DNA polymerase, T4 DNA ligation 
kit, and DNA blunting kit were purchased from Takara Biochemicals (Japan). All reagents for 
DNA synthesis and DNA sequencing were purchased from Applied Biosystems (U.S.A.). The 
plasmid pICD2 carrying the leucine dehydrogenase gene of B. stearothermophilus and the 
plasmid pKPDH2 containing the phenylalanine dehydrogenase gene of T. intermedius were 
described previously [11, 14]. 
 
2.2. Mutagenesis 
Substitutions of aspartate or lysine for L40, glycine for A113, leucine for V291, and 
serine for V294 of LeuDH were performed by the method of Kunkel et al. [34] using a 
commercial kit (Mutan-K), as described previously [35]. The following five oligonucleotide 
primers were synthesized with an Applied Biosystems DNA synthesizer model 381 to contain 
appropriate mismatched bases (indicated by asterisks) in the complementary codons for each 
residue (underlined): 
                              * * *  
L40D: 5’-ATACGCGTCCCGCCTTTCGCCGGGCCGAG-3’ 
                                    * *  
L40K: 5’-ATACGCGTCCCGCCGTCCGCCGGGCCGAG-3’ 
                          *  
A113G: 5’-GACGTCTTCCCCCGTGATGTAG-3’ 
                              *  
V291L: 5’-ACGTTGATGAGGCCGCCGGC-3’ 




After confirming the nucleotide sequence of the mutant gene, appropriate restriction 
fragments were replaced for the corresponding wild-type gene fragments in the LeuDH 
expression plasmid pICD212. 
Substitution of alanine for G114 of PheDH was performed by the two-step PCR 
method as described previously [36] with two mutation primers shown below and pKPDH2 as 
a template (1st PCR): 
 
                                                                                      *  
G114A-sense: 5’-AACGGCCGTTTCTATACCGCAACCGACATGGG-3’ 




After the second PCR using universal primers, the amplified fragment was 
sequenced and digested with SacII and SplI. The digested fragment was replaced for the 
corresponding wild-type gene fragments in pKPDH2.  
 
2.3. Purification of the mutant enzyme 
The wild-type and mutant enzymes of LeuDH were purified to homogeneity from the 
crude extract of recombinant Escherichia coli cells grown at 37 °C for 12 h in Luria broth 
supplemented with 50 µg/ml ampicillin and 0.5 mM IPTG, as described previously [11]. The 
wild-type and G114A mutant of PheDH were also purified to homogeneity from the crude 
extract of recombinant E. coli cells, as described previously [14]. 
 
2.4. Steady-state kinetic analysis 
The oxidative deamination of L-amino acids and the reductive amination of α-keto 
acids were measured by monitoring spectrophotometrically the appearance and disappearance, 
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respectively, of NADH under the conditions described previously [11]. The steady-state 
kinetic parameters were determined by varying systematically the concentrations of both 
substrate and coenzyme, except for ammonia, which was held at a constant, saturating 
concentration (1.0 M). Protein concentrations of the wild-type and mutant LeuDH and the 
wild-type and G114A PheDH were estimated using absorbencies (A0.1%) of 0.851 and 0.634 at 
280 nm, respectively. 
 
2.5. CD measurements 
Circular dichroism (CD) spectra were measured at 25 °C in 10 mM potassium 
phosphate buffer (pH 7.2) with a Jasco spectropolarimeter model J-600. In the calculation of 
the mean residue ellipticity (s), the mean residue weight was taken to be 111 for the enzyme 
protein. The CD spectra were obtained at a protein concentration of 0.2 mg/ml in a 2.0-cm 
light path length cuvette for the measurements in the wavelength region above 250 nm and at 
a protein concentration of 0.1 mg/ml in a 0.1-cm light path length cuvette for measurements 
below 250 nm. 
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3.  Results and Discussion 
3.1. Molecular modeling and construction of mutant enzymes 
Multiple sequence alignment of LeuDH, PheDH, and GluDH using structural 
information of B. sphaericus LeuDH and C. symbiosum GluDH pointed out important 
residues that are assumed to be the determinant of substrate side-chain binding (Fig. 1). This 
homology-based modeling suggests that the difference in substrate specificity between 
PheDH and LeuDH arises only from unacceptable steric interaction of the methyl group of 
A113 of LeuDH with the substrate phenylalanine benzene ring, which are relieved in PheDH 
by critical replacement of this residue by Gly114 [18]. To examine the validity of the models, 
two mutant enzymes of LeuDH, in which Ala113 is replaced by glycine (A113G), and A113 
and V291 are both replaced by glycine and leucine, respectively (A113G/V291L), have been 
constructed. With the expectation of the opposite effect, we also prepared the mutant PheDH, 
in which G114 was changed to alanine (G114A-PheDH) by PCR mutagenesis. 
Furthermore, to alter the specificities of LeuDH toward GluDH or LysDH, L40, 
corresponding to K89 in GluDH, whose ε-amino group interacts with the γ-carboxyl group of 
the substrate L-glutamate by hydrogen bonding, has been mutated to lysine (L40K) or 
aspartate (L40D). V294 of LeuDH, which is equivalent to S379 in GluDH that interacts with 
the substrate glutamate by hydrogen bonding, has been replaced as well by serine for making 
double mutants (L40K/V294S, L40D/V294S). In these variants, the hydrophilicity of the 
substrate side-chain binding pocket increases, and the interaction of the substrate with the 
polar side chain is expected. 
All seven mutant enzymes were expressed and purified from the crude extract of 
recombinant E. coli cells as the wild-type enzymes. After the purification, all mutant enzymes 
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exhibited a single prominent band on the SDS-PAGE gel with molecular sizes equivalent to 
the wild-type LeuDH or PheDH (data not shown). 
 
3.2. CD spectra of mutants 
CD spectra of the wild-type and six mutant enzymes of LeuDH were measured to see 
whether the global conformations were changed by the mutation. All the mutant enzymes 
except A113G/V291L showed CD spectra practically identical with that of the wild-type 
enzyme in the 200-250 nm region (Fig. 2), indicating that the wild-type and these mutant 
enzymes contain very similar secondary structures. The decreased CD band of A113G/V291L 
in this region indicates the decreased secondary structure content and some slight 
conformational changes in the overall structure of this mutant. 
On the other hand, the spectra of mutant enzymes in the 260-290 nm region, which 
reflects the environment of aromatic residues, were significantly different from that of the 
wild-type enzyme (Fig. 2A). The CD band of the wild-type LeuDH in this region is mainly 
due to the sole tryptophan (W46), which is predicted to be located in the vicinity of the active 
site [37]. The decreases in the near-UV CD bands of A113G and A113G/V291L indicate that 
the environment around W46 of these mutants became more hydrophobic than that of the 
wild-type enzyme, as in the case of mutations of the conserved glycine residues adjacent to 
the catalytic K80 [37]. On the contrary, the spectrum of the L40D/V294S mutant in this 
region, which is more negative than that of the wild-type, is indicative of a more hydrophilic 
environment around W46 than in the wild-type enzyme. 
CD spectrum of the G114A mutant of PheDH appeared essentially identical to that of 
the wild-type enzyme (data not shown). Thus, the G114A mutant appears to have an identical 
conformation to that of the wild-type PheDH. 
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3.3. Catalytic properties of A113G and A113G/V291L mutants of LeuDH and G114A 
mutant of PheDH 
Both single and double mutants of LeuDH prepared to mimic PheDH showed a 
marked decrease in activities towards the aliphatic substrates compared to the wild-type 
enzyme. The kcat values of the single mutant A113G and the double mutant A113G/V291L 
decreased by about 20 and 60 folds for L-leucine, and by about 3 and 10 folds for α-keto-iso-
caproate, respectively (Table 2). The substrate specificities of A113G and A113G/V291L 
were examined in the oxidative deamination with various amino acids and in the reductive 
amination with various α-keto acids as substrate at 10 mM. The results are compared with 
those of LeuDH and PheDH in Table 1. Both of the mutant enzymes have broader substrate 
specificities than the wild-type LeuDH. The mutants act on, in addition to the preferred 
substrate of LeuDH (short branched-chain amino acids including L-leucine, L-isoleucine, L-
valine, and their keto-analogs), poor substrates of LeuDH such as L-norleucine, L-norvaline, 
L-methionine, L-ethionine, and α-keto-γ-methylthiobutyrate (long-chain aliphatic substrates). 
Furthermore, these two mutants also utilize L-phenylalanine and phenylpyruvate with over 
10% relative activity for the preferred substrate L-leucine and its keto-analog, while the wild-
type enzyme does not respond at all to the substrates with aromatic side chains. This could be 
attributed to the fact that the methyl side chain of A113 in LeuDH, which sterically interferes 
with binding of the substrate aromatic ring, was removed by substitution to glycine. 
Table 2 summarizes the kcat and Km values of the mutant and wild-type enzymes of 
LeuDH and PheDH. Although the kcat value for L-leucine and its keto analog of the LeuDH 
single mutant decreased considerably, the values for other aliphatic substrates did not change 
so much. In addition, the Km values of A113G for aliphatic substrates are similar to the 
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corresponding values of the wild-type LeuDH. This result suggests that there is no significant 
conformational change in the active site of the mutant upon replacement of A113 with glycine. 
As expected from the molecular modeling, the single mutant showed PheDH activities, even 
though they were merely 4% and 11%, respectively, of those of the wild-type PheDH in the 
oxidative deamination of L-phenylalanine and reductive amination of phenylpyruvate. The Km 
values of the A113G mutant for L-phenylalanine and its keto analog were also over 100 times 
larger than the values of the wild-type PheDH. The low affinities of A113G for both L-
phenylalanine and phenylpyruvate lead to a conclusion that the side-chain methyl group of 
A113 in LeuDH is critical for discrimination between substrates with or without an aromatic 
side chain but its absence does not contribute for increasing the affinity for aromatic 
substrates. 
In contrast with the single mutant, the kcat values of the A113G/V291L double 
mutant of LeuDH greatly decreased with all the aliphatic substrates examined. Furthermore, 
the Km values for all amino acid and α-keto acid substrates increased over 10 folds, although 
there was not such a large change in the Km values for the coenzymes (NAD+ and NADH). 
These results are consistent with the significantly altered CD properties of the double mutant 
in the UV region, as described above. It is plausible that the double mutation has caused some 
perturbation of local conformations in the substrate side-chain binding region. 
The G114A mutant of PheDH showed broader substrate specificity than the wild-
type enzyme, and the relative activity for the aliphatic substrates (L-isoleucine, L-norvaline, 
L-methionine, α-keto-β-methylvalerate, and α-ketobutyrate) increased markedly (Table 1). 
Despite the fact that the A113G mutant of LeuDH is considerably active with phenylalanine 
and phenylpyruvate likely due to the removal of the side-chain methyl group, the G114A 
mutant of PheDH still retains a low activity toward aromatic substrates (4.2% of kcat of the 
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wild-type PheDH for L-phenylalanine, Table 2). The broad substrate specificity of this mutant 
is consistent with the specificities of the corresponding G124A and G124A/L307V mutants of 
B. sphaericus PheDH, which also retained about 5% of activities for substrates with an 
aromatic side chain [32]. Comparing the Km values of the G114A mutant with those of the 
wild-type PheDH, we note that the values for aliphatic substrates are unchanged, although 
those for both L-phenylalanine and phenylpyruvate increased by 160 times. Therefore, we 
conclude that the affinity for aromatic substrates decreases specifically by introducing a 
mutation in this position. The greatly decreased activity and the affinity towards aromatic 
substrates with G114A indicate that G114 in PheDH is indeed critical for recognition of 
aromatic substrates. 
 
3.4. Catalytic properties of L40K and L40K/V294S mutants of LeuDH 
The substrate specificities of the mutants that were designed to mimic the active site 
of GluDH were also studied in both the oxidative deamination and reductive amination 
reactions (Table 3). The specificity of the single mutant L40K, in which L40 of LeuDH has 
been replaced by lysine, corresponding to K89 in GluDH that plays a role in anchoring the γ-
carboxyl group of the substrate L-glutamate, did not change greatly from that of the wild-type 
LeuDH. It could react neither with L-glutamate nor with α-ketoglutarate as substrates. In 
contrast, the double mutant L40K/V294S with an additional mutation of V294 to serine 
(equivalent to S379 in GluDH, interacting with the substrate side chain) has a weak GluDH 
activity, as expected from the molecular modeling. The double mutant of LeuDH acts on 
polar amino acids such as L-asparagine, L-aspartate, L-glutamine, and L-glutamate, in 
addition to the preferred substrates of the wild-type enzyme. 
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The kinetic parameters of the single and double mutants of LeuDH in both 
deamination and amination reactions are presented in Table 4. The single mutant showed 
reduced kcat values as compared to those of the double mutant having similar values with the 
wild-type enzyme. The Km values of the single mutant for L-isoleucine, L-norleucine, α-keto-
iso-caproate, and α-keto-β-methylvalerate increased by more than 10 folds as compared to the 
wild-type. The kinetic parameters of L40K are similar to those obtained with the K89L 
mutant of GluDH, prepared in a manner opposite to the present studies [31]. Both of the 
single mutants (L40K of LeuDH and K89L of GluDH) displayed large reductions in the 
original catalytic activities and failed to reverse the substrate specificities. In the L40K mutant, 
the positively charged lysine side chain has been introduced, but the hydrophobic valine 
remains in position 294. The K89L mutant of GluDH has oppositely the L89/S379 pair. 
Presumably, these incompatible pairings of side chains cannot be stabilized by binding of the 
normal or alternative substrates. 
In marked contrast to the single mutant, the double mutant of LeuDH (L40K/V294S) 
showed kcat values even similar to those of the wild-type enzyme (except for L-leucine). 
However, the double mutant had high Km values for the preferred substrates of LeuDH, like 
the single mutant. Although the single and double mutants had slight activities toward L-
glutamate and α-ketoglutarate, the catalytic rates with the two substrates were unsaturable 
with their concentrations (data not shown); thus the Km values for L-glutamate and α-
ketoglutarate could not be obtained, and the kcat values, determined with the substrate at 50 
mM, shown in Table 4 are a lower limit. The high Km values of the double mutant for 
aliphatic substrates are indicative of the increased hydrophilicity of the pocket that is 
advantageous for binding an acidic substrate, but further fine tuning of the substrate-binding 
pocket is certainly required to realize the high affinity for L-glutamate. 
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3.5. Catalytic Properties of L40D and L40D/V294S mutants of LeuDH 
We constructed another set of mutant enzymes of LeuDH in order to confer the 
activity for the substrates with a positively charged side chain (L-lysine and L-arginine). As 
shown in Table 3, the substrate specificities of the single (L40D) and double (L40D/V294S) 
mutants for aliphatic amino acids were virtually unaffected as compared with the wild-type 
enzyme. These mutants, however, displayed entirely new activities for L-lysine and L-
arginine, even in the single mutant (L40D), unlike in the case of the L40K mutant described 
above. 
However, the substitution of L40 with aspartate caused marked reductions of kcat 
values for aliphatic substrates (lower by ~100 folds) compared with those of the wild-type 
LeuDH (Table 4). Moreover, the Km values for these preferred substrates increased much; for 
example, the values for L-leucine, L-isoleucine, and L-norleucine were too high to determine. 
The large reduction of activities of the mutants for aliphatic substrates seems to be mainly due 
to the increased Km values. The kcat values of the single and double mutants for deamination 
of L-lysine were 0.029 and 0.45 s–1, which were only 0.06 and 0.9%, respectively, of that for 
L-leucine of the wild-type LeuDH. Nevertheless, the Km values of the mutants for L-lysine 
were only one order of magnitude higher than those for aliphatic substrates of the wild-type 
enzyme. These kinetic properties, together with the CD spectrum of the L40D/V294S mutant, 
suggest that the hydrophilicity of the substrate side-chain binding pocket, enhanced by the 
substitutions of L40 by aspartate and V294 by serine, is important in permitting the binding of 




4.  Conclusions 
Enzymes belonging to the amino acid dehydrogenase superfamily have already been 
used to produce various amino acids in commercially feasible quantities. Understanding the 
molecular mechanisms for the distinct substrate specificities displayed by these enzymes 
would enable us to engineer the substrate specificities by site-directed mutagenesis and 
further facilitate their applications to the enzymatic production or detection of novel amino 
acids. 
In the studies herein reported, we constructed three types of mutant enzymes of 
LeuDH to mimic the substrate specificities of PheDH, GluDH, and LysDH by protein 
engineering. The kinetic parameters obtained with these mutants clearly showed that A113, 
V294, L40, and V294 in LeuDH are the key residues involved in recognition of the substrate 
side chain. A113 in LeuDH and the corresponding G114 in PheDH control the volume of the 
side-chain binding pocket and play a critical role in discrimination of the bulkiness of the side 
chain. Emergence of GluDH and LysDH activities in the L40K/V294S and L40D/V294S 
mutants, respectively, indicates that the two residues in the active sites of the amino acid 
dehydrogenases are important for discrimination of the hydrophobicity/polarity/charge of 
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Fig. 1. Sequence alignment of amino acid dehydrogenases using structural information from 
B. sphaericus LeuDH and C. symbiosum GluDH. Residues L40, A113, V291, and V294 of B. 
stearothermophilus LeuDH and their corresponding residues are shown with white letters in 
black background. 
 
Fig. 2. CD spectra of the wild-type and mutant enzymes of LeuDH. The CD spectra were 
recorded at 25 ºC in 10 mM potassium phosphate buffer (pH 7.2). (A) Spectra of the wild-
type (solid line), A113G (broken line), and A113G/V291L (dotted line) mutant enzymes. (B) 
Spectra of the wild-type (solid line), L40K (broken line), and L40K/V294S (dotted line) 
mutant enzymes. (C) Spectra of the wild-type (solid line), L40D (broken line), and 
L40D/V294S (dotted line) mutant enzymes. The unit of [θ] is mdeg•cm2•dmol–1. 
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LeuDH  PheDH Substrate (10 mM) 
Wild type A113G AG/V291L Wild type G114A 
Deamination      
L-Leucine 100 100 100 3.9 42 
L-Isoleucine 54 550 150 0.4 90 
L-Valine 39 62 13 1.3 39 
L-Norleucine 14 530 110 6.3 66 
L-Norvaline 56 110 23 2.1 72 
L-Methionine 0.7 81 19 2.2 72 
L-Ethionine 0 35 12 4.0 11 
L-Alanine 0 0 0 0.4 3.5 
L-Phenylalanine 0 15 11 100 100 
L-Tyrosine 0 0 0 40 5.4 
L-Tryptophan 0 0 0 1.2 0 
L-Histidine 0 0.4 0 0.2 1.3 
L-Glutamate 0 0 0 0 0 
      
Amination      
 α-Keto-iso-caproate 100 100 100 47 151 
 α-Keto-β-methylvalerate 100 180 67 16 174 
 α-Ketovalerate 86 102 19 37 224 
 α-Keto-γ-methylthiobutyrate 15 130 36 55 102 
 α-Ketobutyrate 47 5.1 0.6 5.5 104 
 Phenylpyruvate 0 17 11 100 100 
 p-Hydroxyphenylpyruvate 0 0 0 80 0 
 
a 
Specific activities of the wild-type and mutant enzymes of LeuDH and PheDH for various 
substrates are shown as % activities relative to the values for L-leucine and L-phenylalanine, 
respectively, taken as 100. 
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Table 2. Steady-state kinetic parameters of wild-type and mutant enzymesa 
 
 LeuDH A113G A113G/V291L PheDH G114A 
kcat (s–1)      
L-Leucine 50 ± 3.0 2.8 ± 0.08 0.74 ± 0.010 0.20 ± 0.006 0.12 ± 0.002 
L-Isoleucine 28 ± 0.77 23 ± 0.53 1.4 ± 0.037 0.24 ± 0.02 0.22 ± 0.006 
L-Norleucine 1.3 ± 0.03 18 ± 0.04 0.60 ± 0.018 1.9 ± 0.005 0.16 ± 0.004 
L-Norvaline 13 ± 0.15 7.7 ± 0.19 0.29 ± 0.008 0.59 ± 0.006 0.21 ± 0.004 
L-Phenylalanine 0 0.80 ± 0.004 1.4 ± 0.049 23 ± 0.27 0.97 ± 0.012 
      
α-Keto-iso-caproate 280 ± 22 94 ± 1.9 29 ± 0.35 36 ± 0.49 37 ± 0.48 
α-Keto-β-methyl 
valerate 280 ± 4.1 235 ± 5.2 37 ± 0.52 26 ± 0.22 46 ± 0.24 
α-Ketocaproate 110 ± 2.4 140 ± 2.8 24 ± 0.91 79 ± 1.1 61 ± 0.49 
Phenylpyruvate 0 22 ± 0.70 9.9 ± 1.2 200 ± 1.3 36 ± 0.46 
      
Km (mM)      
L-Leucine 5.1 ± 0.50 1.4 ± 0.10 35 ± 2.5 0.12 ±0.006 0.082 ± 0.002 
L-Isoleucine 2.4 ± 0.15 7.8 ± 0.49 33 ± 1.8 0.081 ± 0.007 0.082 ± 0.003 
L-Norleucine 4.4 ± 0.21 4.1 ± 0.026 24 ± 1.6 0.19 ± 0.002 0.17 ± 0.008 
L-Norvaline 7.8 ± 0.29 27 ± 1.8 70 ± 8.6 0.50 ± 0.016 0.18 ± 0.006 
L-Phenylalanine ─ 31 ± 1.2 66 ± 7.1 0.10 ± 0.003 16 ± 0.42 
      
α-Keto-iso-caproate 0.88 ± 0.15 1.7 ± 0.11 30 ± 2.7 4.4 ± 0.19 4.1 ± 0.16 
α-Keto-β-methyl 
valerate 3.8 ± 0.16 9.4 ± 0.59 69 ± 5.1 12 ± 0.45 5.2 ± 0.067 
α-Ketocaproate 4.7 ± 0.34 2.0 ± 0.10 28 ± 2.9 2.5 ± 0.11 4.4 ± 0.11 
Phenylpyruvate ─ 7.1 ± 1.1 9.9 ± 1.2 0.065 ± 0.003 11 ± 0.47 
      
NAD+ (µM) 63 ± 7 76 ± 1 280 ± 13 170 ± 10 50 ± 20 
NADH (µM) 35 ± 6 42 ± 2 17 ± 7 83 ± 1 27 ± 7 
 
a Steady-state kinetic parameters were determined by varying the concentration of the 
substrate to be measured in the presence of fixed concentrations of the cofactor and co-
substrate (1.25 mM NAD+ in the oxidative deamination and 0.1 mM NADH and 1 M 
ammonia in the reductive amination). 
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 Substrate (10 mM) 
Wild type L40K L40K/V294S L40D L40D/V291S 
Deamination      
 L-Leucine 100 100 100 100 100 
 L-Isoleucine 54 273 187 212 358 
 L-Valine 39 81 26 64 45 
 L-Norleucine 14 28 17 35 27 
 L-Norvaline 56 29 24 37 33 
 L-Methionine 0.7 2.6 3.6 3.0 4.2 
 L-Ethionine 0 0.5 0.2 0 0 
 L-Alanine 0 0.04 0 0 0 
 L-Phenylalanine 0 0 0 0 0 
 L-Histidine 0 0.02 0 0 0 
 L-Asparagine 0 0 0.1 0 0 
 L-Glutamine 0 0 0.4 0 0 
 L-Aspartate 0 0 0.04 0 0 
 L-Glutamate 0 0 0.1 0 0 
 L-Lysine 0 0 0 9.2 38 
 L-Arginine 0 0 0 1.8 1.1 
      
Amination      
 α-Keto-iso-caproate 100 100 100 100 100 
 α-Keto-β-methylvalerate 100 86 58 92 63 
 α-Ketovalerate 86 ND
b
 30 52 ND
b
 
 α-Ketobutyrate 47 ND
b




a Specific activities of the wild-type and mutant enzymes of LeuDH for various substrates are 




Table 4. Steady-state kinetic parameters of wild-type and mutant enzymes of LeuDHa 
 
 Wild type L40K L40K/V294S L40D L40D/V291S 
kcat (s–1)      
 L-Leucine 50 ± 3.0 3.8 ± 0.038 9.8 ± 0.054 0.21b 0.80b 
 L-Isoleucine 28 ± 0.77 1.8 ± 0.41 17 ± 0.46 0.49b 2.8b 
 L-Norleucine 1.3 ± 0.03 1.9 ± 0.04 1.7 ± 0.03 0.070b 0.22b 
 L-Glutamate 0 0 0.02b 0 0 
 L-Lysine 0 0 0 0.029 ± 0.001 0.45 ± 0.03 
      
 α-Keto-iso-caproate 280 ± 22 95 ± 1.7 270 ± 5.9 9.9 ± 0.051 47 ± 0.50 
 α-Keto-β-methyl 
valerate 280 ± 4.1 82 ± 1.6 280 ± 3.5 1.9 ± 0.024 30 ± 0.47 
 α-Ketoglutarate 0 0 0.57b 0 0 
      
Km (mM)      
 L-Leucine 5.1 ± 0.50 5.2 ± 3.7 26 ± 0.52 NDc NDc 
 L-Isoleucine 2.4 ± 0.15 64 ± 1.8 24 ± 1.5 NDc NDc 
 L-Norleucine 4.4 ± 0.21 110 ± 3.0 27 ± 1.1 NDc NDc 
 L-Glutamate ─ ─ NDc ─ ─ 
 L-Lysine ─ ─ ─ 64 ± 3.9 72 ± 5.0 
      
 α-Keto-iso-caproate 0.88 ± 0.15 46 ± 3.2 42 ± 3.3 260 ± 22 120 ± 11 
 α-Keto-β-methyl 
valerate 3.8 ± 0.16 49 ± 3.8 84 ± 6.7 47 ± 2.4 110 ± 14 
 α-Ketoglutarate ─ ─ NDc ─ ─ 
 
a Steady-state kinetic parameters were determined by varying the concentration of the 
substrate to be measured in the presence of fixed concentrations of the cofactor and co-
substrate (1.25 mM NAD+ in the oxidative deamination and 0.1 mM NADH and 1 M 
ammonia in the reductive amination). 
b Determined for the substrate at 50 mM. 










LeuDH B. sphaericus 37GPALGGARMF 109RYITAEDVGTTVSDM 284YVINAGGVINVADELYGY
LeuDH B. stearo. 37GPALGGTRMW 109RYITAEDVGTTVADM 284YVINAGGVINVADELYGY
LeuDH T. intermedius 37GPALGGMRMW 109RYITAEDVGTTVEDM 284YVINAGGVINVADELLGY
PheDH T. intermedius 38GPALGGCRMI 110RFYTGTDMGTNPEDF 287YLVNAGGLIQVADELEGP
PheDH B. sphaericus 48GPALGGTRMY 120RFYTGTDMGTTMDDF 270YLVNAGGLIQVADELEGP
GluDH E. coli 90GPYKGGMRFH 163TDVPAGDIGVGGREV 371KAANAGGVATSGLEMAQN
GluDH C. symbiosum 86GPYKGGLRFA 160IDVPAGDLGVGAREI 370KAVNAGGVLVSGFEMSQN
!c !e "8 "15a "15b
!c !e "4 "12
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